×
About 1,048 results

ALLMedicine™ Barrett Esophagus Center

Research & Reviews  489 results

Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Ne...
https://doi.org/10.1016/j.suc.2021.03.002
The Surgical Clinics of North America; Fedorova E, Watson TJ

May 28th, 2021 - Barrett esophagus (BE), defined as intestinal metaplasia of the distal esophageal mucosa, typically results from chronic gastroesophageal reflux disease and is the only known precursor of esophageal adenocarcinoma. The standard of care for the man...

Nonendoscopic Detection of Barrett Esophagus and Esophageal Adenocarcinoma: Recent Adva...
https://doi.org/10.7326/M20-7164
Annals of Internal Medicine; Iyer PG, Katzka DA

May 3rd, 2021 - Nonendoscopic Detection of Barrett Esophagus and Esophageal Adenocarcinoma: Recent Advances and Implications.|2021|Iyer PG,Katzka DA,|

A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dy...
https://doi.org/10.1007/s10620-021-06863-0 10.1097/PAS.0000000000000598 10.1016/j.gie.2009.06.035 10.1111/j.1365-2036.2011.04901.x 10.1093/jnci/djr203 10.1007/s10620-010-1218-1.pdf 10.1111/j.1572-0241.1998.00362.x 10.1016/S0140-6736(09)60487-6 10.1056/NEJMoa1103042 10.1136/gut.39.1.5 10.1136/bmj.321.7271.1252 10.1097/MEG.0b013e3282f8295d 10.1097/00004836-200305001-00003 10.1136/gutjnl-2013-305372 10.7326/0003-4819-138-3-200302040-00009 10.1136/gut.2009.176701 10.1016/S0092-8674(04)00045-5 10.1038/nrg2634 10.3748/wjg.v16.i5.531 10.1016/j.coph.2009.08.009 10.1002/bjs.7000 10.1158/1078-0432.CCR-09-0385 10.1158/1940-6207.CAPR-12-0276 10.1038/ctg.2013.5 10.1111/j.1572-0241.2000.02002.x 10.4161/cc.9.16.12598 10.18632/oncotarget.3737 10.1038/s41420-018-0133-7 10.1002/stem.2444 10.7314/APJCP.2014.15.23.10181 10.1186/1479-5876-11-10 10.1177/0022034514531018 10.1093/jmcb/mjr046 10.3892/mmr.2014.2361 10.7314/APJCP.2013.14.12.7081 10.4161/epi.21236 10.1038/cddis.2017.356 10.1038/aps.2016.92 10.1038/sj.bjc.6606028 10.1016/j.bbadis.2015.06.002 10.1016/j.biopha.2017.10.069 10.1261/rna.045757.114 10.1016/j.biopha.2019.109041 10.18632/oncotarget.16802 10.1111/j.1572-0241.1999.01276.x 10.1046/j.1365-2036.2002.01146.x
Digestive Diseases and Sciences; Saller J, Jiang K et. al.

Mar 13th, 2021 - Progression of Barrett esophagus (BE) to esophageal adenocarcinoma occurs among a minority of BE patients. To date, BE behavior cannot be predicted on the basis of histologic features. We compared BE samples that did not develop dysplasia or carci...

Long-term (18 Years) Results of Patients With Long-segment Barrett's Esophagus Submitte...
https://doi.org/10.1097/SLA.0000000000004760
Annals of Surgery; Csendes A, Orellana O et. al.

Jan 20th, 2021 - To determine late results of AS-DD procedure in long-segment (LSBE) and extralong-segment BE (ELSBE) using subjective and objective measurements to ascertain the histological impact over intestinal metaplasia (IM) and progression to EAC. Barrett e...

Gastroesophageal Reflux Disease: A Review.
https://doi.org/10.1001/jama.2020.21360
JAMA Maret-Ouda J, Markar SR et. al.

Dec 22nd, 2020 - Gastroesophageal reflux disease (GERD) is defined by recurrent and troublesome heartburn and regurgitation or GERD-specific complications and affects approximately 20% of the adult population in high-income countries. GERD can influence patients' ...

see more →

Guidelines  5 results

Endoscopic eradication therapy for patients with Barrett’s esophagus–associated dysplasia an...
https://www.asge.org/docs/default-source/education/practice_guidelines/piis0016510717324082.pdf?sfvrsn=0
Sachin Wani

Feb 2nd, 2018 - Barrett’s esophagus (BE) is defined by the replacement of the normal squamous epithelium of the distal esophagus with metaplastic intestinal-type columnar epithelium. 1, 2, 3 BE is an adverse event of chronic GERD and the only identifiable premalig.

Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagu...
https://www.asge.org/docs/default-source/education/practice_guidelines/piis0016510717301906.pdf?sfvrsn=2
Sachin Wani

May 29th, 2017 - The objective of this study was to use a methodologically rigorous process to develop valid quality indicators for EET in the management of patients with BE-related neoplasia. Defining quality indicators has the potential to optimize the managemen.

The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus...
https://doi.org/10.1097/PAS.0000000000000819
The American Journal of Surgical Pathology; Srivastava A, Appelman H et. al.

Mar 1st, 2017 - Barrett esophagus (BE) is a known risk factor for the development of esophageal adenocarcinoma. Pathologists play a critical role in confirming the diagnosis of BE and BE-associated dysplasia. As these diagnoses are not always straightforward on r...

Diagnosis and Management of Barrett’s Esophagus
https://gi.org/guideline/diagnosis-and-management-of-barretts-esophagus/
Nicholas J. Shaheen

Nov 2nd, 2015 - Barrett’s esophagus (BE) is among the most common conditions encountered by the gastroenterologist. In this document, the American College of Gastroenterology updates its guidance for the best practices in caring for these patients.

Esophageal Cancer Prevention (PDQ®)–Health Professional Version
https://www.cancer.gov/types/esophageal/hp/esophageal-prevention-pdq?cid=eb_govdel
National Cancer Institute

Smoking and drinking alcohol may account for roughly 90% of esophageal squamous cell carcinoma cases in Western countries like the United States.[1] Gastroesophageal reflux/Barrett esophagus is associated with an increased risk of esophageal adeno...

see more →

Clinicaltrials.gov  525 results

Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Ne...
https://doi.org/10.1016/j.suc.2021.03.002
The Surgical Clinics of North America; Fedorova E, Watson TJ

May 28th, 2021 - Barrett esophagus (BE), defined as intestinal metaplasia of the distal esophageal mucosa, typically results from chronic gastroesophageal reflux disease and is the only known precursor of esophageal adenocarcinoma. The standard of care for the man...

Nonendoscopic Detection of Barrett Esophagus and Esophageal Adenocarcinoma: Recent Adva...
https://doi.org/10.7326/M20-7164
Annals of Internal Medicine; Iyer PG, Katzka DA

May 3rd, 2021 - Nonendoscopic Detection of Barrett Esophagus and Esophageal Adenocarcinoma: Recent Advances and Implications.|2021|Iyer PG,Katzka DA,|

A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dy...
https://doi.org/10.1007/s10620-021-06863-0 10.1097/PAS.0000000000000598 10.1016/j.gie.2009.06.035 10.1111/j.1365-2036.2011.04901.x 10.1093/jnci/djr203 10.1007/s10620-010-1218-1.pdf 10.1111/j.1572-0241.1998.00362.x 10.1016/S0140-6736(09)60487-6 10.1056/NEJMoa1103042 10.1136/gut.39.1.5 10.1136/bmj.321.7271.1252 10.1097/MEG.0b013e3282f8295d 10.1097/00004836-200305001-00003 10.1136/gutjnl-2013-305372 10.7326/0003-4819-138-3-200302040-00009 10.1136/gut.2009.176701 10.1016/S0092-8674(04)00045-5 10.1038/nrg2634 10.3748/wjg.v16.i5.531 10.1016/j.coph.2009.08.009 10.1002/bjs.7000 10.1158/1078-0432.CCR-09-0385 10.1158/1940-6207.CAPR-12-0276 10.1038/ctg.2013.5 10.1111/j.1572-0241.2000.02002.x 10.4161/cc.9.16.12598 10.18632/oncotarget.3737 10.1038/s41420-018-0133-7 10.1002/stem.2444 10.7314/APJCP.2014.15.23.10181 10.1186/1479-5876-11-10 10.1177/0022034514531018 10.1093/jmcb/mjr046 10.3892/mmr.2014.2361 10.7314/APJCP.2013.14.12.7081 10.4161/epi.21236 10.1038/cddis.2017.356 10.1038/aps.2016.92 10.1038/sj.bjc.6606028 10.1016/j.bbadis.2015.06.002 10.1016/j.biopha.2017.10.069 10.1261/rna.045757.114 10.1016/j.biopha.2019.109041 10.18632/oncotarget.16802 10.1111/j.1572-0241.1999.01276.x 10.1046/j.1365-2036.2002.01146.x
Digestive Diseases and Sciences; Saller J, Jiang K et. al.

Mar 13th, 2021 - Progression of Barrett esophagus (BE) to esophageal adenocarcinoma occurs among a minority of BE patients. To date, BE behavior cannot be predicted on the basis of histologic features. We compared BE samples that did not develop dysplasia or carci...

Fast Five Quiz: Gastroesophageal Reflux Disease Management
https://reference.medscape.com/viewarticle/945392

Feb 11th, 2021 - Gastroesophageal reflux disease (GERD) affects as many as 28% of North American residents. Marked by an excessive backup of gastric contents into the esophagus leading to troublesome symptoms and/or complications, it can result from dysfunction of...

Long-term (18 Years) Results of Patients With Long-segment Barrett's Esophagus Submitte...
https://doi.org/10.1097/SLA.0000000000004760
Annals of Surgery; Csendes A, Orellana O et. al.

Jan 20th, 2021 - To determine late results of AS-DD procedure in long-segment (LSBE) and extralong-segment BE (ELSBE) using subjective and objective measurements to ascertain the histological impact over intestinal metaplasia (IM) and progression to EAC. Barrett e...

see more →

News  29 results

Fast Five Quiz: Gastroesophageal Reflux Disease Management
https://reference.medscape.com/viewarticle/945392

Feb 11th, 2021 - Gastroesophageal reflux disease (GERD) affects as many as 28% of North American residents. Marked by an excessive backup of gastric contents into the esophagus leading to troublesome symptoms and/or complications, it can result from dysfunction of...

Swallowable 'Sponge on String' to Diagnose Esophageal Cancer
https://www.staging.medscape.com/viewarticle/935559

Aug 11th, 2020 - An experimental cell-collection device that can be administered without anesthesia in a primary care practice was shown to be better at detecting Barrett esophagus than the standard of care in a community-based clinical trial. Use of this patient-...

Swallowable 'Sponge on String' to Diagnose Esophageal Cancer
https://www.medscape.com/viewarticle/935559

Aug 11th, 2020 - An experimental cell-collection device that can be administered without anesthesia in a primary care practice was shown to be better at detecting Barrett esophagus than the standard of care in a community-based clinical trial. Use of this patient-...

Current management of Barrett esophagus and esophageal adenocarcinoma
https://www.mdedge.com/ccjm/article/211196/gastroenterology/current-management-barrett-esophagus-and-esophageal/page/0/2?channel=280

Nov 1st, 2019 - Vitamin D: No evidence of benefit Vitamin D affects genes regulating proliferation, apoptosis, and differentiation, and has therefore been studied as a potential antineoplastic agent. Its deficiency has also been associated with increased risk of.

Cost Analysis Supports Radiofrequency Ablation for Barrett Esophagus With Low-Grade Dysplasia
https://www.medscape.com/viewarticle/878010

Apr 5th, 2017 - The Cost-Effectiveness of Radiofrequency Ablation for Barrett's Esophagus With Low-Grade Dysplasia: Results From a Randomized Controlled Trial (SURF Trial) Phoa KN, Rosmolen WD, Weusten BL, et al Gastrointest Endosc. 2016 Dec 9. [Epub ahead of pri...

see more →